Bsure Medical Bsure Medical was founded in 2020, and has a strategic alliance with the multinational company FAGRON, Bsure's industrial partner and investor. Bsure operates in the biotechnology sector and its first product is a genetic kit for the prediction of severe adverse reactions to subcutaneous implants (Dermal Fillers). Founders on the part of the VHIR Dr. Simo Schwartz Vall d’Hebron University Hospital Dr. Jaume Alijotas Head of the Systemic Diseases research group
